Nine months have passed since Sanofi unveiled plans to separate its Consumer Healthcare (CHC) business but analysts and investors still have no definitive answer on how the French firm intends to execute the split.
CFO François-Xavier Roger at a meeting with UBS analysts in June reiterated the three options under consideration: a partial sale to/joint venture with private equity; an initial public offering; or a spin-off